A pilot study to build a database on seven anti-hypertensive drugs

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 1, 2005, Pages 41-46

  Fujita, Toshiharu ^a   Miura, Yoshihiko ^b   Mayama, Takeshi ^c  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^c RAD AR Council   (Japan)

Author keywords

Anti hypertensive; Database; Drug use investigation; Post marketing surveillance; Re examination

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG INFORMATION; DRUG MARKETING; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HUMAN; HYPERTENSION; INFORMATION PROCESSING; JAPAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SIDE EFFECT; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIHYPERTENSIVE AGENTS; COMPUTER SYSTEMS; DATA COLLECTION; DATABASES, FACTUAL; DRUG INDUSTRY; GOVERNMENT REGULATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; JAPAN; LEGISLATION, DRUG; PHARMACOEPIDEMIOLOGY; PILOT PROJECTS;

EID: 11844267251     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1021     Document Type: Article

References (6)

1. Reexamination System. In Drug Approval and Licensing Procedures in Japan. Jiho, Inc.: Tokyo, Japan, 2000; 653-659.
2. Hirayama K. Postmarketing safety administration in Japan. Drug Inf J 1994; 28: 421-426.
3. Shimizu N. Postmarketing surveillance in Japan. Drug Inf J 1994; 28: 419-420.
4. Kusunoki T. Post-marketing surveillance and pharmacoepidemiology in Japan. Eur J Clin Res 1994; 6: 74-78.
5. Assurance of Post-marketing Efficacy and Safety. In Drug Approval and Licensing Procedures in Japan 2000. Jiho, Inc.: Tokyo, Japan, 2000; 633-636.
6. GPMSP. In Drug Approval and Licensing Procedures in Japan 2000. Jiho, Inc.: Tokyo, Japan, 2000; 666-667.